Abbott backs India’s drug patent regime

The government has received support from an unexpected quarter in its battle against the US on the intellectual property (IP) regime. Amid an uproar for action against India by Big Pharma, American drug major Abbott has told the US International Trade Commission (USITC) that it is "not currently facing any significant challenges with respect to intellectual property protection in India".

Read Full Story>>